Giovanni Passalacqua

Summary

Affiliation: University of Genoa
Country: Italy

Publications

  1. ncbi Complementary and alternative medicine for the treatment and diagnosis of asthma and allergic diseases
    G Passalacqua
    Allergy and Respiratory Diseases, Department of Internal Medicine, University of Genoa, Italy
    Monaldi Arch Chest Dis 63:47-54. 2005
  2. ncbi Quantitative assessment of the compliance with a once-daily sublingual immunotherapy regimen in real life (EASY Project: Evaluation of A novel SLIT formulation during a Year)
    Giovanni Passalacqua
    J Allergy Clin Immunol 117:946-8. 2006
  3. ncbi ARIA update: I--Systematic review of complementary and alternative medicine for rhinitis and asthma
    Giovanni Passalacqua
    Allergy and Respiratory Diseases, University of Genoa, Italy
    J Allergy Clin Immunol 117:1054-62. 2006
  4. ncbi New insights in sublingual immunotherapy
    Giovanni Passalacqua
    Allergy and Respiratory Diseases, DIMI, Padiglione Maragliano, L go R Benzi 10, 16132 Genoa Italy
    Curr Allergy Asthma Rep 6:407-12. 2006
  5. ncbi Sublingual immunotherapy: update 2006
    Giovanni Passalacqua
    Allergy and Respiratory Diseases, Department of Internal Medicine, University of Genoa, Genoa, Italy
    Curr Opin Allergy Clin Immunol 6:449-54. 2006
  6. ncbi Lack of neo-sensitization to Pen a 1 in patients treated with mite sublingual immunotherapy
    Renato E Rossi
    Allergy Unit, National Health Service, Rete di Allergologia Regione Piemonte, Cuneo 1, Italy
    Clin Mol Allergy 8:4. 2010
  7. ncbi An update on the asthma-rhinitis link
    Giovanni Passalacqua
    Allergy and Respiratory Diseases, Department of Internal Medicine, Genoa University, Italy
    Curr Opin Allergy Clin Immunol 4:177-83. 2004
  8. ncbi Sublingual immunotherapy
    Giovanni Passalacqua
    Department of Internal Medicine, University of Genoa, Italy
    Rev Alerg Mex 50:220-5. 2003
  9. ncbi Latex-jujube cross-reactivity: case report and immunological study
    C Lombardi
    Allergy and Respiratory Diseases, Department of Internal Medicine Padiglione Maragliano, L.go R. Benzi 10, 16132 Genoa, Italy
    Allergy 60:971-2. 2005
  10. ncbi Advances in allergen-specific immunotherapy
    Giovanni Passalacqua
    DIMI, University of Genoa, Italy
    Curr Drug Targets 10:1255-62. 2009

Detail Information

Publications114 found, 100 shown here

  1. ncbi Complementary and alternative medicine for the treatment and diagnosis of asthma and allergic diseases
    G Passalacqua
    Allergy and Respiratory Diseases, Department of Internal Medicine, University of Genoa, Italy
    Monaldi Arch Chest Dis 63:47-54. 2005
    ..Therefore these tests must not be used, since they can lead to delayed or incorrect diagnosis and therapy...
  2. ncbi Quantitative assessment of the compliance with a once-daily sublingual immunotherapy regimen in real life (EASY Project: Evaluation of A novel SLIT formulation during a Year)
    Giovanni Passalacqua
    J Allergy Clin Immunol 117:946-8. 2006
  3. ncbi ARIA update: I--Systematic review of complementary and alternative medicine for rhinitis and asthma
    Giovanni Passalacqua
    Allergy and Respiratory Diseases, University of Genoa, Italy
    J Allergy Clin Immunol 117:1054-62. 2006
    ..There are also unresolved safety concerns. Therapeutic efficacy of complementary-alternative treatments for rhinitis and asthma is not supported by currently available evidence...
  4. ncbi New insights in sublingual immunotherapy
    Giovanni Passalacqua
    Allergy and Respiratory Diseases, DIMI, Padiglione Maragliano, L go R Benzi 10, 16132 Genoa Italy
    Curr Allergy Asthma Rep 6:407-12. 2006
    ..Additionally, the mechanisms of action are beginning to be systematically studied. Some points need further investigation, such as the effect in asthma, the mechanisms of action, and the optimal dose to be administered...
  5. ncbi Sublingual immunotherapy: update 2006
    Giovanni Passalacqua
    Allergy and Respiratory Diseases, Department of Internal Medicine, University of Genoa, Genoa, Italy
    Curr Opin Allergy Clin Immunol 6:449-54. 2006
    ..In the past 2 years, new data concerning clinical, immunological and practical aspects of sublingual immunotherapy have been published, and many critical points have been addressed...
  6. ncbi Lack of neo-sensitization to Pen a 1 in patients treated with mite sublingual immunotherapy
    Renato E Rossi
    Allergy Unit, National Health Service, Rete di Allergologia Regione Piemonte, Cuneo 1, Italy
    Clin Mol Allergy 8:4. 2010
    ..Some studies reported the possible induction of food allergy, caused by neo-sensitization to cross-reacting allergens, during immunotherapy with aeroallergens, while other studies ruled out such possibility...
  7. ncbi An update on the asthma-rhinitis link
    Giovanni Passalacqua
    Allergy and Respiratory Diseases, Department of Internal Medicine, Genoa University, Italy
    Curr Opin Allergy Clin Immunol 4:177-83. 2004
    ..For the present article we collected and reviewed the more relevant experimental results concerning the asthma-rhinitis link in allergic diseases, published since January 2002...
  8. ncbi Sublingual immunotherapy
    Giovanni Passalacqua
    Department of Internal Medicine, University of Genoa, Italy
    Rev Alerg Mex 50:220-5. 2003
    ..This paper reviews the up-to-date aspects about clinical efficacy, safety and pharmacokinetics of sublingual immunotherapy...
  9. ncbi Latex-jujube cross-reactivity: case report and immunological study
    C Lombardi
    Allergy and Respiratory Diseases, Department of Internal Medicine Padiglione Maragliano, L.go R. Benzi 10, 16132 Genoa, Italy
    Allergy 60:971-2. 2005
  10. ncbi Advances in allergen-specific immunotherapy
    Giovanni Passalacqua
    DIMI, University of Genoa, Italy
    Curr Drug Targets 10:1255-62. 2009
    ..The last frontier seems to be the manipulation of genoma with replicons and allergen-encoding plasmids...
  11. ncbi Non-injection routes for allergen immunotherapy: focus on sublingual immunotherapy
    Giovanni Passalacqua
    Allergy and Respiratory Diseases, Department of Internal Medicine, University of Genoa, Italy
    Inflamm Allergy Drug Targets 5:43-51. 2006
    ..Several points still need to be elucidated, including: mechanisms of action, optimal dosages, and indications in pediatric patients...
  12. ncbi Rhinitis, rhinosinusitis and quality of life in children
    G Passalacqua
    Allergy and Respiratory Diseases, Department of Internal Medicine, University of Genoa, Genoa, Italy
    Pediatr Allergy Immunol 18:40-5. 2007
    ..It has become clear that the QoL questionnaires measure the aspects of the disease that partially differ from the routinely evaluated parameters and that QoL should integrate, not replace, the objective measurements...
  13. ncbi Allergic rhinitis and its impact on asthma update: allergen immunotherapy
    Giovanni Passalacqua
    Allergy and Respiratory Diseases, Department of Internal Medicine, University of Genoa, Genoa, Italy
    J Allergy Clin Immunol 119:881-91. 2007
    ..Novel approaches for immunotherapy are currently under evaluation, including the use of adjuvants, peptides, and DNA-conjugated and recombinant allergens...
  14. ncbi Sublingual immunotherapy: an update
    Giovanni Passalacqua
    Allergy and Respiratory Diseases, Department of Internal Medicine, University of Genoa, Genoa, Italy
    Curr Opin Allergy Clin Immunol 4:31-6. 2004
    ..Recently published studies have provided answers to some of these points...
  15. ncbi Quantitative assessment of the compliance with once-daily sublingual immunotherapy in children (EASY project: evaluation of a novel SLIT formulation during a year)
    Giovanni Passalacqua
    Allergy and Respiratory Diseases, DIMI, University of Genoa, Genoa, Italy
    Pediatr Allergy Immunol 18:58-62. 2007
    ..4%) for side effects probably related to therapy. These data obtained in a quite large sample of children and in real-life confirm that the compliance with SLITOne is good, despite the therapy managed at home...
  16. ncbi Euro coins and contact dermatitis
    C Lombardi
    Allergy and Respiratory Diseases, Department of Internal Medicine, Pad. Maragliano, Largo R. Benzi 10, 16132 Genoa, Italy
    Allergy 59:669-70. 2004
  17. ncbi Efficacy and safety of sublingual immunotherapy
    Giovanni Passalacqua
    Allergy and Respiratory Diseases, Department of Internal Medicine, University of Genoa, Genoa, Italy
    Ann Allergy Asthma Immunol 93:3-12; quiz 12-3, 103. 2004
    ....
  18. ncbi Comparison of the effects in the nose and skin of a single dose of desloratadine and levocetirizine over 24 hours
    Giovanni Passalacqua
    Allergy and Respiratory Diseases, Department of Internal Medicine, University of Genoa, Genoa, Italy
    Int Arch Allergy Immunol 135:143-7. 2004
    ..We compared the effects of a single dose of the two drugs in the nose and skin over 24 h...
  19. ncbi Allergy and the lung
    G Passalacqua
    Allergy and Respiratory Diseases, Department of Internatl Medicine, San Martino Hospital, Padigliano Maragliano, Italy
    Clin Exp Immunol 153:12-6. 2008
    ..The recent introduction of biological treatments (monoclonal antibodies) has allowed elucidation of some of the pathogenic features of allergic asthma...
  20. ncbi Pharmacokinetics of radiolabelled Par j 1 administered intranasally to allergic and healthy subjects
    G Passalacqua
    Allergy and Respiratory Diseases, University of Genoa, Genoa, Italy
    Clin Exp Allergy 35:880-3. 2005
    ..Local nasal immunotherapy is accepted as an alternative to the injection route for allergic rhinitis. Despite this, little is known about the kinetics of the allergen after nasal delivery in allergic subjects...
  21. ncbi Novel therapeutic interventions for allergic rhinitis
    Giovanni Passalacqua
    University of Genoa, Padiglione Maragliano, Allergy and Respiratory Diseases, Department of Internal Medicine, Largo Rossana Benzi 10, Genoa, Italy
    Expert Opin Investig Drugs 15:1615-25. 2006
    ..Finally, one of the major goals is to modify the T(H)2-biased immune response by improving the characteristics and modes of action of allergen immunotherapy...
  22. ncbi Specific immunotherapy: beyond the clinical scores
    Giovanni Passalacqua
    Allergy and Respiratory Diseases, University of Genoa, Italy
    Ann Allergy Asthma Immunol 107:401-6. 2011
    ..The literature is reviewed to evaluate the available experimental data on this...
  23. ncbi A review of the evidence from comparative studies of levocetirizine and desloratadine for the symptoms of allergic rhinitis
    Giovanni Passalacqua
    Allergy and Respiratory Diseases, Department of Internal Medicine, University of Genoa, Italy
    Clin Ther 27:979-92. 2005
    ..Levocetirizine and desloratadine are newer antihistamines indicated for the treatment of allergic rhinitis and chronic idiopathic urticaria...
  24. ncbi Sublingual immunotherapy for allergic respiratory diseases: efficacy and safety
    Giovanni Passalacqua
    Allergy and Respiratory Diseases, Department of Internal Medicine, University of Genoa, Padiglione Maragliano, Largo Rosanna Benzio 10, 16132 Genoa, Italy
    Immunol Allergy Clin North Am 31:265-77, ix. 2011
    ..The sublingual route (SLIT) seemed to be a good candidate for the clinical practice because of its satisfactory safety profile and is now considered an acceptable alternative to SCIT in adults and children...
  25. ncbi Specific immunotherapy in asthma: efficacy and safety
    G Passalacqua
    Allergy and Respiratory Diseases, University of Genoa, Genoa, Italy
    Clin Exp Allergy 41:1247-55. 2011
    ..In such case, a measurable clinical benefit on asthma symptoms can be expected. On the other hand, SIT cannot be presently recommended as single therapy when asthma is the unique manifestation of respiratory allergy...
  26. ncbi Sublingual immunotherapy for allergic rhinitis: an update
    Giovanni Passalacqua
    Allergy and Respiratory Diseases, Department of Internal Medicine, University of Genoa, Genoa, Italy
    Curr Opin Otolaryngol Head Neck Surg 19:43-7. 2011
    ..We will review herein a brief history of SLIT, its indications and the safety aspects and will discuss the main unmet needs and the points to be developed in the field...
  27. ncbi Allergic and non-allergic rhinitis in swimmers: clinical and cytological aspects
    Matteo Gelardi
    Department of Otolaryngology II, University of Bari, Bari, Italy
    Br J Sports Med 46:54-8. 2012
    ..The aim of this study was to detail the clinical and cytological characteristics of rhinitis in swimmers, and to assess the possible role of chlorine-induced symptoms...
  28. ncbi Investigational drugs for allergic rhinitis
    Giovanni Passalacqua
    University of Genoa, Allergy and Respiratory Diseases, Department of Internal Medicine, Padiglione Maragliano, 16132 Genoa, Italy
    Expert Opin Investig Drugs 19:93-103. 2010
    ..Thus, an intense research activity is presently ongoing with the aim of improving the characteristics and modes of action of this treatment...
  29. ncbi Allergic rhinitis in women
    Giovanni Passalacqua
    University of Genoa, Allergy and Respiratory Diseases, Department of Internal Medicine, PadiglioneMaragliano, L go R Benzi 10, 16132, Genoa, Italy
    Womens Health (Lond Engl) 3:603-11. 2007
    ..This review will examine the aforementioned aspects, with particular regard to the pharmacotherapy of rhinitis in pregnancy...
  30. ncbi Levocetirizine in persistent allergic rhinitis: continuous or on-demand use? A pilot study
    Giorgio Walter Canonica
    University of Genoa, Allergy and Respiratory Diseases, Department of Internal Medicine, Genoa, Italy
    Curr Med Res Opin 24:2829-39. 2008
    ..According to the ARIA initiative, it is classified as intermittent and persistent, the latter being the most troublesome...
  31. ncbi The possible influence of the environment on respiratory allergy: a survey on immigrants to Italy
    Carlo Lombardi
    Allergy Unit, Department of Internal Medicine, Sant Orsola Hospital, Brescia, Italy
    Ann Allergy Asthma Immunol 106:407-11. 2011
    ..Respiratory allergy is influenced and determined by genetic and environmental factors. Migration is a good model to indirectly evaluate the possible influence of environment...
  32. ncbi Sublingual and oral immunotherapy
    Giorgio Walter Canonica
    Allergy and Respiratory Diseases, Department of Internal Medicine, University of Genoa, Padiglione Maragliano, L go R Benzi 10, Genoa 16132, Italy
    Immunol Allergy Clin North Am 24:685-704, vii. 2004
    ..The indications for SLIT are similar to those for the subcutaneous route. A long-lasting effect has been demonstrated for the sublingual route, but data are needed to determine the optimal dose and the preventive effect in asthma...
  33. ncbi Randomized open comparison of the safety of SLIT in a no-updosing and traditional updosing schedule in patients with Parietaria allergy
    Laura Guerra
    Allergy and Respiratory Diseases, Department of Internal Medicine, University of Genoa, Genoa, Italy
    Allergol Immunopathol (Madr) 34:82-3. 2006
    ....
  34. ncbi Pharmacokinetics of Der p 2 allergen and derived monomeric allergoid in allergic volunteers
    Marcello Bagnasco
    Medical and Radiometabolic Therapy, University of Genoa, Genoa, Italy
    Int Arch Allergy Immunol 138:197-202. 2005
    ..The contribution of enteric absorption of the allergoid in the mechanism of action of sublingual immunotherapy remains to be defined...
  35. ncbi Specific immunotherapy for respiratory allergy: state of the art according to current meta-analyses
    Enrico Compalati
    Allergy and Respiratory Diseases, Department of Internal Medicine, University of Genoa, Genoa, Italy
    Ann Allergy Asthma Immunol 102:22-8. 2009
    ..To evaluate the efficacy of allergen specific immunotherapy in the treatment of allergic asthma and rhinitis as derived by the available meta-analyses...
  36. ncbi Role of contact sensitization in chronic urticaria
    Laura Guerra
    Allergy and Respiratory Diseases, Department of Internal Medicine, University of Genoa, Italy
    J Am Acad Dermatol 56:88-90. 2007
    ..In all patients, avoidance measures led to a complete remission within 1 month. We suggest that testing for contact sensitization can be helpful in the management of chronic urticaria...
  37. ncbi Safety of allergen-specific sublingual immunotherapy and nasal immunotherapy
    Giovanni Passalacqua
    Allergy and Respiratory Diseases, Department of Internal Medicine, Genoa University, Genoa, Italy
    Chem Immunol Allergy 82:109-18. 2003
    ..Its safety is also supported by pharmacokinetics and immunological data. Experimental data on the safety of sublingual and nasal immunotherapy will be reviewed...
  38. ncbi Metaanalysis of the efficacy of sublingual immunotherapy in the treatment of allergic asthma in pediatric patients, 3 to 18 years of age
    Martin Penagos
    Division of Allergy and Respiratory Diseases, Department of Internal, edicine, University of Genoa, Genoa, Italy
    Chest 133:599-609. 2008
    ..We evaluated the efficacy of SLIT in the treatment of allergic asthma in children by a metaanalysis of randomized, double-blind, and placebo-controlled (DBPC) clinical trials...
  39. ncbi The clinical characteristics of respiratory allergy in immigrants in northern Italy
    Carlo Lombardi
    Allergy Unit, Department of Internal Medicine, Sant Orsola Hospital, Brescia, Italy
    Int Arch Allergy Immunol 147:231-4. 2008
    ..Migration is a good epidemiological model to indirectly assess the influence of the environment. We assessed the clinical characteristics of respiratory allergy in immigrants in Brescia, Italy...
  40. ncbi Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: a meta-analysis of randomized, placebo-controlled, double-blind trials
    Martin Penagos
    Allergy and Respiratory Diseases, Department of Internal Medicine, University of Genoa, Italy
    Ann Allergy Asthma Immunol 97:141-8. 2006
    ..CONCLUSION: The results of this meta-analysis showed that,compared with placebo, SLIT with standardized extracts is effective in pediatric patients with allergic rhinitis...
  41. ncbi Clinical and therapeutic aspects of allergic asthma in adolescents
    Carlo Lombardi
    Allergy and Respiratory Unit, Department of Internal Medicine, S. Orsola Hospital, Brescia, Italy
    Pediatr Allergy Immunol 14:453-7. 2003
    ..From a clinical and functional point of view, asthma in adolescents did not differ from other age ranges. Nevertheless, the management (diagnosis and therapy) emerged to be unsatisfactory from many points of view...
  42. ncbi Nasal eosinophils display the best correlation with symptoms, pulmonary function and inflammation in allergic rhinitis
    Giorgio Ciprandi
    Head-Neck Department, S. Martino Hospital, Genoa, Italy
    Int Arch Allergy Immunol 136:266-72. 2005
    ..CONCLUSION: Eosinophils in the nasal smear display the best correlation with all the clinical and immunological parameters in allergic rhinitis and also correlate well with methacholine response...
  43. ncbi The safety of allergen specific sublingual immunotherapy
    Giovanni Passalacqua
    Allergy and Respiratory Diseases, Department of Internal Medicine, University of Genoa, Genoa, Italy
    Curr Drug Saf 2:117-23. 2007
    ..Finally, it seems that the occurrence of some adverse events, at variance with injection route, does not depend strictly on the dose of allergen administered...
  44. ncbi Effects of fexofenadine and other antihistamines on components of the allergic response: adhesion molecules
    Giorgio Ciprandi
    Allergy and Respiratory Diseases, Department of Internal Medicine, University of Genoa, Genoa, Italy
    J Allergy Clin Immunol 112:S78-82. 2003
    ....
  45. ncbi Allergy and the nose
    G Ciprandi
    Semeiotica e Metodologia Medica I, Department of Internal Medicine, University of Genoa, Genoa, Italy
    Clin Exp Immunol 153:22-6. 2008
    ..Therefore, the management of AR patients should be rigorously careful and multi-disciplinary...
  46. ncbi The functional connection between oral allergy syndrome and united airways disease assessed by oral challenge
    Carlo Lombardi
    Allergy Unit, Department of Internal Medicine, Sant Orsola Hospital, Brescia, Italy
    Ann Allergy Asthma Immunol 108:30-3. 2012
    ..The airways and the upper digestive tract have a common embryonic origin. In sensitized subjects they can respond to allergens with an immediate reaction (asthma, rhinitis, or oral allergy syndrome [OAS])...
  47. ncbi Emerging sublingual immunotherapy drugs
    Enrico Compalati
    University of Genoa, Allergy and Respiratory Diseases Clinic, Department of Internal Medicine, Italy
    Expert Opin Pharmacother 11:2963-72. 2010
    ..Sublingual immunotherapy (SLIT) has gained increasing interest for its efficacy comparable to traditional subcutaneous immunotherapy and its good safety profile...
  48. ncbi Impact of bariatric surgery on pulmonary function and nitric oxide in asthmatic and non-asthmatic obese patients
    Carlo Lombardi
    Allergy Unit, Department of Internal Medicine, Sant Orsola Poliambulanza Hospital, Brescia, Italy
    J Asthma 48:553-7. 2011
    ..Asthma is an important co-morbidity of obesity. This study evaluated the impact of bariatric surgery on respiratory function in obese patients and compared the outcomes in asthmatic and non-asthmatic subjects...
  49. ncbi Oral and sublingual immunotherapy in paediatric patients
    Giovanni Passalacqua
    Department of Internal Medicine, University of Genoa, Italy
    Curr Opin Allergy Clin Immunol 3:139-45. 2003
    ..Some aspects, such as the dose-response relationship and preventive effect, will be a research challenge for future developments and better definition of indications in children...
  50. ncbi Allergen biodistribution in humans
    Marcello Bagnasco
    Allergy and Clinical Immunology Unit, Department of Internal Medicine, Genoa University, Genoa, Italy
    Chem Immunol Allergy 82:33-43. 2003
    ..These data are potentially useful to improve immunotherapy treatment protocols by noninjectable routes...
  51. ncbi Noninjection routes for immunotherapy
    Giorgio Walter Canonica
    Division of Allergy and Respiratory Diseases, Department of Internal Medicine, University of Genoa, Italy
    J Allergy Clin Immunol 111:437-48; quiz 449. 2003
    ..Although the long-lasting efficacy has been recently documented for the sublingual route, several points still need to be elucidated, including mechanisms of action, optimal dosage, cost-effectiveness, and adherence...
  52. ncbi Levocetirizine in persistent allergic rhinitis and asthma: effects on symptoms, quality of life and inflammatory parameters
    M Pasquali
    Allergy and Respiratory Diseases, DIMI, University of Genoa, Genoa, Italy
    Clin Exp Allergy 36:1161-7. 2006
    ..In the active group, only two patients used rescue medications compared with 13 patients in the placebo group. Conclusions LCZ is clinically effective and capable of improving the rhinitis-asthma-related QoL...
  53. ncbi Clinical and cytologic characteristics of allergic rhinitis in elderly patients
    Maria Teresa Ventura
    Department of Internal Medicine, Immunology and Infectious Diseases, University of Bari, Bari, Italy
    Ann Allergy Asthma Immunol 108:141-4. 2012
    ..Thus, special attention to allergic diseases in elderly people has begun to emerge, but little is known about the effect and features of allergic rhinitis in elderly people...
  54. ncbi Emerging anti-inflammatory agents for allergic rhinitis
    Giorgio Ciprandi
    Dipartimento Patologie Testa Collo, Azienda Ospedaliera Universitaria San Martino, Allergologia U O ORL, Largo R Benzi 10, 16132 Genoa, Italy
    Expert Opin Emerg Drugs 10:689-705. 2005
    ..Finally, one of the major goals is to modify the TH2-biased immune response by improving the characteristics and modes of action of allergen immunotherapy...
  55. ncbi Sublingual immunotherapy: other indications
    Giovanni Passalacqua
    Allergy and Respiratory Diseases, Department of Internal Medicine, University of Genoa, Padiglione Maragliano, Largo R Benzi 10, Genoa 16132, Italy
    Immunol Allergy Clin North Am 31:279-87, ix. 2011
    ..In hymenoptera allergy, the only trial available is a proof-of-concept study in large local reactions that needs to be confirmed in well-controlled studies...
  56. ncbi Targeted therapy for allergic asthma: predicting and evaluating response to omalizumab
    Francesco Tarantini
    Pulmunologist, PhD Student, DIMI University of Genoa, Allergy and Respiratory Diseases, Padiglione Maragliano, Largo R Benzi, 16132 Genova, Italy
    Expert Rev Clin Immunol 3:463-7. 2007
    ..The results established that it is difficult to predict which patients will gain most benefit from treatment, according to pretreatment baseline characteristics...
  57. ncbi Single-dose oral tolerance test with alternative compounds for the management of adverse reactions to drugs
    Giovanni Passalacqua
    Allergy and Respiratory Diseases, DIMI, Department of Internal Medicine, Genoa University, Italy
    Int Arch Allergy Immunol 129:242-7. 2002
    ..Adverse reactions to drugs are common in the clinical practice. Many outpatients are frequently referred to allergists in order to determine which drugs they can safely take in the future...
  58. ncbi Long-term cetirizine treatment reduces allergic symptoms and drug prescriptions in children with mite allergy
    G Ciprandi
    Allergy and Immunology Clinic, Genoa, Italy
    Ann Allergy Asthma Immunol 87:222-6. 2001
    ..This suggests that long-term continuous treatment be included in the global strategy of allergy treatment...
  59. ncbi Underdiagnosis and undertreatment of asthma: a 9-year study of Italian conscripts
    G Ciprandi
    Allergy and Respiratory Diseases, DIMI, University of Genoa, Italy
    Int Arch Allergy Immunol 125:211-5. 2001
    ..During the last 20 years, the epidemiology of asthma has been investigated in various populations, thus providing interesting data including the accuracy of diagnosis and the adequacy of treatment...
  60. ncbi The safety of sublingual immunotherapy with one or more allergens in adults
    C Lombardi
    Allergy and Respiratory Diseases, Department of Internal Medicine, Padiglione Maragliano, L.go R. Benzi 10, 16132 Genoa, Italy
    Allergy 63:375-6. 2008
  61. ncbi Intranasal mometasone furoate reduces late-phase inflammation after allergen challenge
    G Ciprandi
    Allergy and Respiratory Diseases, Department of Internal Medicine, University of Genoa, Italy
    Ann Allergy Asthma Immunol 86:433-8. 2001
    ..Topical corticosteroids have been accepted as a highly effective anti-inflammatory therapy for allergic rhinitis...
  62. ncbi Efficacy of mometasone furoate nasal spray in the treatment of allergic rhinitis. Meta-analysis of randomized, double-blind, placebo-controlled, clinical trials
    M Penagos
    Allergy and Respiratory Diseases Clinic, Department of Internal Medicine, Universita degli Studi di Genova, Genoa, Italy
    Allergy 63:1280-91. 2008
    ....
  63. ncbi Role of leukotriene receptor antagonists in the management of mild-to-moderate asthma
    M Milanese
    Department of Internal Medicine, University of Genoa, Italy
    Monaldi Arch Chest Dis 56:508-13. 2001
    ..For this reason, even if ICS are superior to LTRAs in controlling asthma outcomes and in improving pulmonary function, in children and elderly patients LTRAs can be considered an alternative to low-dose ICS...
  64. ncbi Asthma treatment: 'magic bullets which seek their own targets'
    F Tarantini
    Allergy and Respiratory Diseases, DIMI University of Genoa, Genova, Italy
    Allergy 62:605-10. 2007
    ..In fact, it proved to reduce exacerbations and symptom scores, and to improve quality of life, with a very good safety profile...
  65. ncbi The asthma-rhinitis association: between the clinical hypothesis and the scientific theory
    Giovanni Passalacqua
    Allergy and Respiratory Diseases--Department of Internal Medicine, University of Genoa, Padiglione Maragliano, Largo R. Benzi, 10, 16132 Genoa, Italy
    Curr Allergy Asthma Rep 3:191-3. 2003
  66. ncbi Effects on symptoms and quality of life of hypertonic saline nasal spray added to antihistamine in persistent allergic rhinitis--a randomized controlled study
    A Rogkakou
    Allergy and Respiratory Diseases, DIMI, University of Genoa
    Eur Ann Allergy Clin Immunol 37:353-6. 2005
  67. ncbi The efficacy of sublingual immunotherapy for house dust mites respiratory allergy: results of a GA2LEN meta-analysis
    E Compalati
    Allergy and Respiratory Disease Clinic, Department of Internal Medicine, University of Genoa, Genoa, Italy
    Allergy 64:1570-9. 2009
    ..These findings suggest that more data are needed, derived from large-population-based high quality studies, and corroborated by objective outcomes, mainly for AA...
  68. ncbi Rhinasthma: a new specific QoL questionnaire for patients with rhinitis and asthma
    I Baiardini
    Allergy and Respiratory Diseases, DIMI, Genoa University, Genoa, Italy
    Allergy 58:289-94. 2003
    ..It provides a short and simple assessment, and has overall psychometric properties. This is of relevance because of the frequent asthma-rhinitis comorbidity...
  69. ncbi Economic evaluation of sublingual immunotherapy: an analysis of literature
    G Ciprandi
    Dipartimento di malattie immuno allergologiche, Semeiotica Medica I, Ospedale Universitario S Martino, Genoa, Italy
    Eur Ann Allergy Clin Immunol 39:21-6. 2007
    ..The data obtained, although the number of studies is still limited, provide preliminary evidence supporting a SLIT effect on sparing costs for respiratory allergy...
  70. ncbi Aerobiologic diagnosis of brassicaceae-induced asthma
    A Fiorina
    Allergy and Respiratory Diseases, Department of Internal Medicine, Pad.Maragliano, L.go R.Benzi 10, 16132 Genoa, Italy
    Allergy 58:829-30. 2003
  71. ncbi Randomized double-blind controlled study with sublingual carbamylated allergoid immunotherapy in mild rhinitis due to mites
    G Passalacqua
    Allergy and Respiratory Diseases, Department of Internal Medicine, University of Genoa, Genoa, Italy
    Allergy 61:849-54. 2006
    ..The need for extra visits was significantly lower in the active group (25%vs 43%). CONCLUSIONS: Sublingual immunotherapy was clinically effective and safe in mite-induced mild disease...
  72. ncbi Localized eosinophilic ileitis with mastocytosis successfully treated with oral budesonide
    C Lombardi
    Allergy and Respiratory Diseases, Department of Internal Medicine, Genoa, Italy
    Allergy 62:1343-5. 2007
  73. ncbi Impact of rhinitis on airway inflammation: biological and therapeutic implications
    G Passalacqua
    Allergy and Respiratory Diseases, Department of Internal Medicine, University of Genoa, Italy
    Respir Res 2:320-3. 2001
    ..We discuss some of the recent observations on the nose-lung interaction and some of the novel therapeutic approaches used to treat rhinitis and asthma that arise from this...
  74. ncbi The nose-lung interaction in allergic rhinitis and asthma: united airways disease
    G Passalacqua
    Allergy and Respiratory Diseases, Department of Internal Medicine, Genoa University, Italy
    Curr Opin Allergy Clin Immunol 1:7-13. 2001
    ..In this article, therefore, we collected and reviewed the most relevant experimental results available to support the hypothesis for united airways disease and the studies conducted on the possible mechanisms of nose-lung interaction...
  75. ncbi Oral and sublingual immunotherapy: general aspects and critical considerations
    G Passalacqua
    Department of Allergy and Respiratory Diseases, Genoa University, Italy
    Wien Med Wochenschr 149:433-7. 1999
    ..Furthermore, SLIT reduces time and money expenses usually required by SIT since it is self-administered...
  76. ncbi Continuing medical education. The point of view of asthmatic patients at the beginning of a mandatory CME system
    F Braido
    Allergy and Respiratory Diseases, DIMI, Genoa University, Genoa, Italy
    J Investig Allergol Clin Immunol 14:274-7. 2004
    ....
  77. ncbi Looking for immunotolerance: a case of allergy to baker's yeast (Saccharomyces cerevisiae)
    G B Pajno
    Allergy and Respiratory Diseases, DIMI, University of Genoa, Italy
    Allerg Immunol (Paris) 37:271-2. 2005
    ..We speculate that the continuous exposure to saccharomyces in foods may have lead to an immunotolerance with a progressive reduction of symptoms, whereas why the allergens is active only in ready-baked foods remains unexplained...
  78. ncbi Sublingual immunotherapy in the treatment of adult allergic rhinitis patients
    G W Canonica
    Allergy and Respiratory Diseases, DIMI, University of Genoa, Padiglione Maragliano, Genoa, Italy
    Allergy 61:20-3. 2006
    ..Key priorities for further investigation are the mechanisms of action, the efficacy in asthma, the cost/effectiveness and the identification of those patients who will achieve the maximum benefit with SLIT...
  79. ncbi Treating the allergic patient: think globally, treat globally
    G Passalacqua
    Allergy and Respiratory Diseases, Department of Internal Medicine, University of Genoa, Italy
    Allergy 57:876-83. 2002
  80. ncbi Melkersson-Rosenthal syndrome associated with parvovirus B19 viraemia and haemophagocytic lymphohistiocytosis
    A De Maria
    Allergy and Respiratory Diseases, DIMI, University of Genoa, Genoa, Italy
    Clin Exp Dermatol 34:e623-5. 2009
    ..This observation suggests a possible association between PB19 and HL, and opens the possibility of its association also with acute-onset MRS. Further investigations for the presence of PB19 in cases of MRS are warranted...
  81. ncbi Specific immunotherapy among Italian specialists
    C Lombardi
    Department of Internal Medicine Padiglione Maragliano, Genoa, Italy
    Allergy 61:898-9. 2006
  82. ncbi Seasonal and perennial allergic rhinitis: is this classification adherent to real life?
    G Ciprandi
    Head-Neck Department, S. Martino Hospital, Genoa, Italy
    Allergy 60:882-7. 2005
    ..05). CONCLUSIONS: This study provides evidence that up to 80% of allergic rhinitics have a mixed form, and SAR and PAR definitions are poorly adherent to real life. Lung involvement is frequent in patients reporting nose symptoms alone...
  83. ncbi Pattern of use and diagnostic value of complementary/alternative tests for adverse reactions to food
    G Senna
    Allergy and Respiratory Diseases, Department of Internal Medicine, Padiglione Maragliano, L.go R. Benzi 10, 16132 Genoa, Italy
    Allergy 60:1216-7. 2005
  84. ncbi Allergen-specific sublingual immunotherapy for respiratory allergy
    G Passalacqua
    Allergy and Respiratory Diseases, Department of Internal Medicine, Genoa University, Genoa, Italy
    BioDrugs 15:509-19. 2001
    ..It is intended to be used in association with proper pharmacological treatment, at the earliest stages of the disease, for optimal management of respiratory allergy...
  85. ncbi Severe respiratory allergy induced by indirect exposure to rabbit dander: a case report
    G Liccardi
    Allergy and Respiratory Diseases, Department of Internal Medicine, Pad. Maragliano, L.go R.Benzi 10 16132, Genoa, Italy
    Allergy 59:1237-8. 2004
  86. ncbi Allergic rhinitis in the Italian population evaluated through the national database of general practitioners
    L G Mantovani
    Allergy and Respiratory Diseases, Department of Internal Medicine Padiglione Maragliano, L.go R. Benzi 10, 16132 Genoa, Italy
    Allergy 62:569-71. 2007
  87. ncbi Recommendations for standardization of clinical trials with Allergen Specific Immunotherapy for respiratory allergy. A statement of a World Allergy Organization (WAO) taskforce
    G W Canonica
    Allergy and Respiratory Diseases, DIMI, University of Genoa, Genoa, Italy
    Allergy 62:317-24. 2007
    ..This document summarizes the recommendations for study design, patients' selection, appropriate outcomes and statistical treatment to be used in planning and performing clinical trials with specific immunotherapy...
  88. ncbi Correlation among FEV, nitric oxide and asthma control test in newly diagnosed asthma
    G Senna
    Allergy and Respiratory Diseases, Department of Internal Medicine, Padiglione Maragliano, L go R Benzi 10 16132, Genoa, Italy
    Allergy 62:207-8. 2007
  89. ncbi Aerobiological diagnosis of respiratory allergy by a personal sampler: two case reports
    A Fiorina
    DIMI, University of Genoa, Italy
    J Investig Allergol Clin Immunol 13:284-5. 2003
    ..We suggest that, in selected cases of difficult diagnosis the presence of proximity allergens is suspected, aerobiological sampling with a portable device should be considered...
  90. ncbi Sublingual immunotherapy for large local reactions caused by honeybee sting: a double-blind, placebo-controlled trial
    Maurizio G Severino
    Allergy Clinic, Nuovo Ospedale San Giovanni di Dio, Florence, Italy
    J Allergy Clin Immunol 122:44-8. 2008
    ..Sublingual immunotherapy (SLIT) proved effective and safe in respiratory allergy, and thus its use in hymenoptera allergy can be hypothesized...
  91. ncbi Sublingual immunotherapy in mite-sensitized children with atopic dermatitis: a randomized, double-blind, placebo-controlled study
    Giovanni B Pajno
    Department of Pediatrics, Allergy Unit, University of Messina, Messina, Italy
    J Allergy Clin Immunol 120:164-70. 2007
    ..Atopic dermatitis often has an allergic component, and immunotherapy may therefore prove beneficial...
  92. ncbi Clinical, functional, and immunologic effects of sublingual immunotherapy in birch pollinosis: a 3-year randomized controlled study
    Maurizio Marogna
    Pneumology Unit, Cuasso al Monte, Macchi Hospital Foundation, Varese, Italy
    J Allergy Clin Immunol 115:1184-8. 2005
    ..CONCLUSION: SLIT achieved a significant clinical benefit in birch pollinosis, reduced the eosinophil infiltration in nasal mucosa, and significantly improved pulmonary function during the pollen seasons...
  93. ncbi Non-injection routes for immunotherapy of allergic diseases
    Erkka Valovirta
    Turku Allergy Center, Turku, Finland
    Clin Allergy Immunol 18:607-23. 2004
  94. ncbi New perspectives in the treatment of allergic rhinitis and asthma in children
    Carlos E Baena-Cagnani
    Faculty of Medicine, Catholic University of Cordoba, Cordoba, Argentina
    Curr Opin Allergy Clin Immunol 7:201-6. 2007
    ..Once inflammation is established, potent anti-inflammatory agents or mediator antagonists could help control the phenomenon and reduce the characteristic symptoms related to severity...
  95. ncbi Quantitative assessment of the adherence to sublingual immunotherapy
    Carlo Lombardi
    J Allergy Clin Immunol 113:1219-20. 2004
  96. ncbi Safety and pharmacoeconomics of a cluster administration of mite immunotherapy compared to the traditional one
    Marina Mauro
    S. Anna Hospital, Como
    Allerg Immunol (Paris) 38:31-4. 2006
    ..95 euros per patient in the build-up phase. The cluster up-dosing is as safe as the traditional one and allows a significant economical save...
  97. ncbi Asthma mortality, inhaled steroids, and changing asthma therapy in Argentina (1990-1999)
    Hugo Neffen
    Respiratory Medicine Unit, O. Alassia Children's Hospital, Santa Fe, and Allergy and Respiratory Diseases, Faculty of Medicine, Catholic University, Cordoba, Argentina
    Respir Med 100:1431-5. 2006
    ..CONCLUSION: The increased sale of ICS and possibly the decrease of theophylline use seem to be the more relevant factors associated with decreased asthma mortality in Argentina...
  98. ncbi Sublingual immunotherapy in pediatric patients: beyond clinical efficacy
    Carlos E Baena-Cagnani
    Faculty of Medicine, Catholic University of Cordoba, Argentina
    Curr Opin Allergy Clin Immunol 5:173-7. 2005
    ..We review here the most recent literature on SLIT, with particular attention paid to the safety of children and to the additional clinical effects...
  99. ncbi Sensitization to rabbit allergens in Italy--a multicentre study in atopic subjects without occupational exposure
    Gennaro Liccardi
    Division of Pneumology and Allergology, Department of Chest Diseases, A. Cardarelli Hospital, Naples, Italy
    Int Arch Allergy Immunol 141:295-9. 2006
    ..A progressive increase in rabbit sensitization is expected in the future as consequence of the increased rabbit ownership...
  100. ncbi [Immunotherapy in Latin America. From the past to the future]
    Carlos E Baena Cagnani
    Universidad Catolica de Cordoba, Argentina
    Rev Alerg Mex 55:33-7. 2008
    ....
  101. ncbi Treatment of acquired cold urticaria with cetirizine and zafirlukast in combination
    Patrizia Bonadonna
    Allergy Service, Verona General Hospital, Verona, Italy
    J Am Acad Dermatol 49:714-6. 2003
    ..They were clinically evaluated, after each regimen, by means of a visual analog scale and ice-cube test. The combination therapy was superior to the 2 drugs given alone, as testified by subjective and objective evaluations...